Bortezomib Induces Anti–Multiple Myeloma Immune Response Mediated by cGAS/STING Pathway Activation

Overview of attention for article published in Blood Cancer Discovery, April 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)

Mentioned by

twitter: 8 X users

Citations

dimensions_citation: 74 Dimensions

Readers on

mendeley: 46 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 74 publications that cite this research output.

74

The most recent citing publications are shown below. View all 74 publications that cite this research output on Dimensions.

Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone

Preprint in medRxiv (April 2024)

Targeting immunogenic cell stress and death for cancer therapy

Article in Nature Reviews Drug Discovery (April 2024)

A novel small molecule inhibitor of CD73 triggers immune-mediated multiple myeloma cell death

Article in Blood Cancer Journal (April 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.